Citigroup’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $12.8K | Hold |
|
|||||
|
2025
Q1 | $12.7K | Hold |
|
|||||
|
2024
Q4 | $13.3K | Sell |
|
|||||
|
2024
Q3 | $48.9K | Hold |
|
|||||
|
2024
Q2 | $45.4K | Sell |
|
|||||
|
2024
Q1 | $55K | Hold |
|
|||||
|
2023
Q4 | $56K | Hold |
|
|||||
|
2023
Q3 | $48.5K | Hold |
|
|||||
|
2023
Q2 | $52.1K | Hold |
|
|||||
|
2023
Q1 | $53.4K | Sell |
|
|||||
|
2022
Q4 | $82.7K | Hold |
|
|||||
|
2022
Q3 | $77K | Hold |
|
|||||
|
2022
Q2 | $75K | Hold |
|
|||||
|
2022
Q1 | $81K | Sell |
|
|||||
|
2021
Q4 | $133K | Sell |
|
|||||
|
2021
Q3 | $231K | Sell |
|
|||||
|
2021
Q2 | $388K | Buy |
|
|||||
|
2021
Q1 | $356K | Buy |
|
|||||
|
2020
Q4 | $336K | Sell |
|
|||||
|
2020
Q3 | $277K | Sell |
|
|||||
|
2020
Q2 | $332K | Hold |
|
|||||
|
2020
Q1 | $265K | Buy |
|
|||||
|
2019
Q4 | $297K | Buy |
|
|||||
|
2019
Q3 | $251K | Hold |
|
|||||
|
2019
Q2 | $283K | Buy |
|
|||||
|
2019
Q1 | $289K | Buy |
|
|||||
|
2018
Q4 | $242K | Buy |
|
|||||
|
2018
Q3 | $262K | Buy |
|
|||||
|
2018
Q2 | $238K | Buy |
|
|||||
|
2018
Q1 | $209K | Buy |
|
|||||
|
2017
Q4 | $198K | Buy |
|
|||||
|
2017
Q3 | $197K | Buy |
|
|||||
|
2017
Q2 | $141K | Buy |
|
|||||
|
2017
Q1 | $122K | Sell |
|
|||||
|
2016
Q4 | $135K | Sell |
|
|||||
|
2016
Q3 | $196K | Hold |
|
|||||
|
2016
Q2 | $173K | Sell |
|
|||||
|
2016
Q1 | $314K | Sell |
|
|||||
|
2015
Q4 | $470K | Sell |
|
|||||
|
2015
Q3 | $448K | Sell |
|
|||||
|
2015
Q2 | $601K | Buy |
|
|||||
|
2015
Q1 | $517K | Buy |
|
|||||
|
2014
Q4 | $460K | Buy |
|
|||||
|
2014
Q3 | $385K | Sell |
|
|||||
|
2014
Q2 | $366K | Buy |
|
|||||
|
2014
Q1 | $290K | Buy |
|
|||||
|
2013
Q4 | $124K | Buy |
|
|||||
|
2013
Q3 | $77K | Hold |
|
|||||
|
2013
Q2 | $64K | Buy |
|